Martin Scholz
Executive Board
Leukocare Biotechnology
Germany
Biography
Martin Scholz founded the company. As CSO (chief scientific officer) he is responsible for the development of LEUKOCARE’s technology portfolio. His expertise lies in the therapeutic modulation of de-regulated immune responses and resulting tissue damage by biofunctional medical devices. Martin‘s research sparked the idea to modulate the immune system by means of extracorporeal immune therapy.
Research Interest
Immunology
